Regeneron Pharma Says EMA’s CHMP Adopts Positive Opinion Recommending Approval Of Alternative Dosing Schedule For Libtayo Across All Approved Indications

Benzinga

2026.10.16 11:03 (GMT+0)

Benzinga에서 열기